Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00223145
What this trial is testing

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

Who this might be right for
Prostate Cancer
Abdenour Nabid 600
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Early research (Phase 1)WithdrawnNCT00005827
What this trial is testing

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT02296229
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage III Prostate Cancer
Jonsson Comprehensive Cancer Center 220
Testing effectiveness (Phase 2)Ended earlyNCT00058214
What this trial is testing

Perifosine in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)Study completedNCT00127478
What this trial is testing

A Long Term Safety Study With Atrasentan

Who this might be right for
Prostate CancerAdenocarcinoma
Abbott 166
Large-scale testing (Phase 3)Study completedNCT00003607
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 450
Testing effectiveness (Phase 2)Ended earlyNCT05676463
What this trial is testing

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
Thomas Jefferson University 6
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Not applicableLooking for participantsNCT03880422
What this trial is testing

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Who this might be right for
Cancer SurvivorObesityOverweight+17 more
Roswell Park Cancer Institute 50
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00561262
What this trial is testing

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 60
Testing effectiveness (Phase 2)Ended earlyNCT00526591
What this trial is testing

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Jorge A. Garcia, MD 17
Large-scale testing (Phase 3)Study completedNCT00003026
What this trial is testing

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 966
Not applicableStudy completedNCT00685516
What this trial is testing

Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 113
Large-scale testing (Phase 3)Study completedNCT00394511
What this trial is testing

Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 408
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284
What this trial is testing

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Rutgers, The State University of New Jersey 90
Large-scale testing (Phase 3)Study completedNCT00541047
What this trial is testing

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Who this might be right for
Gastrointestinal ComplicationsProstate CancerSexual Dysfunction+1 more
University College, London 4,236
Testing effectiveness (Phase 2)Looking for participantsNCT06173362
What this trial is testing

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Who this might be right for
Advanced Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
University of California, Davis 75
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Next Page